Evaluation of GFAP, S100B, and UCHL-1 Levels in Children With Refractory Epilepsy
Journal of Child Neurology · 2024-08 · 39 (9-10) · 317-323
DOI: 10.1177/08830738241273339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child Neurology, online erschienen am 19.08.2024. Verfasst von Halil Ural Aksoy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Celal Bayar University Faculty of Medicine, Manisa, Turkey. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, S100 Calcium Binding Protein beta Subunit, Glial Fibrillary Acidic Protein, Drug Resistant Epilepsy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
A number of biomarkers are used to evaluate the duration of the epileptic seizure and the interictal period following neuronal injury. Invasive diagnostic methods are increasingly being replaced by peripheral or minimally invasive biomarkers that give results faster and are more secure.
Purpose
We aimed to evaluate serum glial fibrillary acidic protein (GFAP), S100B, and ubiquitin C-terminal hydrolase (UCHL-1) levels in children with epilepsy.
Methods
Our study included 3 groups: a nonrefractory epilepsy group, a refractory epilepsy group, and a control group. The GFAP, S100B, and UCHL-1 levels in serum samples collected 2-24 hours after the last seizure were analyzed using enzyme-linked immunosorbent assays.
Results
A total of 69 children participated in the study, with 35 participants in the refractory epilepsy group, 18 in the nonrefractory epilepsy group, and 16 in the control group. The GFAP values in the refractory (25.4 ng/mL) and nonrefractory (26.1 ng/mL) epilepsy groups were found to be statistically significantly higher than those in the control group (17.9 ng/mL; P = .001). The S100B values were found to be significantly higher in the refractory epilepsy group (34.13 pg/mL) than in both the control group and the nonrefractory epilepsy group (28.05 pg/mL; P = .028). No significant differences were observed in the UCHL-1 levels between the 3 groups.
Conclusions
We conclude that the observed differences may be due to the increased expression of S100B and GFAP caused by increased and repetitive neuronal damage in refractory epilepsies compared with nonrefractory epilepsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Neurology, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
ORCID-Profile: Sibgatullah Ali Orak, Senem Ayça
Zitieren
APA
Aksoy, H. U., Yılmaz, C., Orak, S. A., Ayça, S., & Polat, M. (2024). Evaluation of GFAP, S100B, and UCHL-1 Levels in Children With Refractory Epilepsy. Journal of Child Neurology, 39(9-10), 317-323. https://doi.org/10.1177/08830738241273339
Vancouver
Aksoy HU, Yılmaz C, Orak SA, Ayça S, Polat M. Evaluation of GFAP, S100B, and UCHL-1 Levels in Children With Refractory Epilepsy. Journal of Child Neurology. 2024;39(9-10):317-323. doi:10.1177/08830738241273339
BibTeX
@article{Aksoy2024,
author = {Aksoy, Halil Ural and Yılmaz, Celil and Orak, Sibgatullah Ali and Ayça, Senem and Polat, Muzaffer},
title = {Evaluation of GFAP, S100B, and UCHL-1 Levels in Children With Refractory Epilepsy},
journal = {Journal of Child Neurology},
year = {2024},
volume = {39},
number = {9-10},
pages = {317--323},
doi = {10.1177/08830738241273339}
}
EUVIMED